Inspra and Weakness - a phase IV clinical study of FDA data
Summary:
Weakness is found among people who take Inspra, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Inspra and have Weakness. It is created by eHealthMe based on reports of 3,117 people who have side effects when taking Inspra from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,117 people reported to have side effects when taking Inspra.
Among them, 167 people (5.36%) have Weakness.
What is Inspra?
Inspra has active ingredients of eplerenone. It is often used in high blood pressure. eHealthMe is studying from 3,171 Inspra users for its effectiveness, alternative drugs and more.
What is Weakness?
Weakness is found to be associated with 5,238 drugs and 6,212 conditions by eHealthMe.
Number of Inspra and Weakness reports submitted per year:
Time on Inspra when people have Weakness *:
Gender of people who have Weakness when taking Inspra*:
Age of people who have Weakness when taking Inspra *:
Common drugs people take besides Inspra *:
Common side effects people have besides Weakness *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Inspra and have Weakness?
Check whether Weakness is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of eplerenone:
- Weakness and drugs with ingredients of eplerenone (481 reports)
Alternative drugs to, pros and cons of Inspra:
- Inspra (3,171 reports)
Common Inspra side effects:
- Breathing difficulty: 286 reports
- Hypotension (abnormally low blood pressure): 221 reports
- Diarrhea: 183 reports
- Fatigue (feeling of tiredness): 181 reports
- Dizziness: 174 reports
- Weakness: 167 reports
- Hyperkalemia (damage to or disease of the kidney): 147 reports
- High blood pressure: 134 reports
Browse all side effects of Inspra:
a b c d e f g h i j k l m n o p q r s t u v w x y zWeakness treatments and more:
- Weakness (513,318 reports)
COVID vaccines that are related to Weakness:
- Weakness in Moderna COVID Vaccine
- Weakness in Pfizer BioNTech Covid Vaccine
- Weakness in Johnson and Johnson Covid Vaccine
Common drugs associated with Weakness:
- Prednisone: 26,970 reports
- Aspirin: 26,881 reports
- Humira: 16,920 reports
- Methotrexate: 16,130 reports
- Metformin: 15,821 reports
- Omeprazole: 15,424 reports
- Tysabri: 14,800 reports
- Lisinopril: 14,469 reports
- Lipitor: 14,239 reports
- Synthroid: 13,523 reports
All the drugs that are associated with Weakness:
- Weakness (5,238 drugs)
Common conditions associated with Weakness:
- Multiple sclerosis: 44,040 reports
- High blood pressure: 24,528 reports
- Rheumatoid arthritis: 22,785 reports
- High blood cholesterol: 17,735 reports
- Pain: 15,184 reports
- Osteoporosis: 13,578 reports
All the conditions that are associated with Weakness:
- Weakness (6,212 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on eplerenone (the active ingredients of Inspra) and Inspra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vancomycin Hcl and Blood Pressure Fluctuation - 8 seconds ago
- Cytovene Iv and Metabolic Alkalosis - 19 seconds ago
- Morphine and Benadryl drug interaction - 22 seconds ago
- Blastomycosis and moderna covid vaccine - 34 seconds ago
- Phentermine and Iodine Allergy - 42 seconds ago
- Crixivan and Musculoskeletal Pain - 49 seconds ago
- Fish Oil and Garcinia Cambogia drug interaction - 59 seconds ago
- Tivicay and Pharyngitis - a minute ago
- Loprox and Multiple Myeloma - a minute ago
- Vancomycin and Sepsis Syndrome - a minute ago